Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)
Episode Description
This activity was supported by an educational grant from Bristol Myers Squibb. Please go to academiccme.com/ccrwestsle and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.